Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glovia is a Japan-based healthcare and nutraceutical company focused on dietary supplements for cognitive health and aging-related conditions. The company is best known for its Feru-guard product line, which uses ferulic acid and Garden Angelica extract and is marketed in Japan through medical institutions for memory and cognitive support. Glovia emphasizes accumulation of safety, basic research, and clinical study data for its products, and it operates a dedicated myelin research institute in Yokohama. In addition to Feru-guard, the company markets other health products including M-Guard, Carmine, Guard One, V-Cure, and egoma hydrogen products. Overall, it appears to be a commercial-stage supplement company operating adjacent to healthcare rather than a traditional biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glovia.